PDRNEvidence library
PDRNEvidence library

Tools

INCI Translator

Learn

Topical vs InjectableHow PDRN WorksHomeWhat is PDRN

Evidence

Evidence libraryProduct databaseRetracted & correctedHow we grade studies

Site

About

PI3K/Akt pathway

G_PI3K_AKT
MechanismBack to all terms

What does this word mean?

A pathway that PDRN upregulates to enhance tissue repair, involving cell survival and proliferation.

Expanded note

Supporting evidence currently comes mainly from animal models and reviews. There is no direct human PI3K/Akt endpoint measurement.

A real example from our data

Not a generic example.

PMID 42270475 observed changes in the PI3K/Akt pathway in a lung ischemia-reperfusion injury model.

Related terms

Protein kinase A (PKA)The downstream effector kinase of cAMP and the signalling cascade node from which multiple pathways branch.Vascular endothelial growth factor (VEGF)The pro-angiogenic factor whose expression is upregulated by PDRN, forming the basis of therapeutic angiogenesis.Collagen synthesisPDRN stimulates collagen production, the core phenotypic endpoint behind repair and regeneration framing.

Where this term appears

How PDRN Works · step 5 →
medium
PMID 40231205; PMID 42270475
PMID 40231205; PMID 42270475

Educational reference only. This site does not provide medical advice, treatment courses, injection counts, clinic recommendations or price recommendations.

PDRN is not approved by the FDA for injection or any therapeutic use. Topical and injectable PDRN are parallel facts under different regulatory pathways and must not be directly equated.

PN is not PDRN. Evidence grades are labelled on every factual element; in vitro and animal research is never described as clinical efficacy.